參考文獻/References:
[1] GOSSIEL F,PAGGIOSI M A,NAYLOR K E,et al.The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis:the T-score bone marker approach in the TRIO study[J].Bone,2020,131:115158.
[2] SI L,WINZENBERG T M,JIANG Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporos Int,2015,26(7):1929-1937.
[3] HURTADO-NAVARRO I,GARCÍA-SEMPERE A,RODRÍGUEZ-BERNAL C,et al.Impact of drug safety warnings and cost-sharing policies on osteoporosis drug utilization in Spain:a major reduction but with the persistence of over and underuse.Data from the ESOSVAL cohort from 2009 to 2015[J].Front pharmacol,2019,10:768.
[4] 劉魏,童培建,肖魯偉,等.益骨湯口服聯(lián)合太極拳鍛煉治療老年性骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(11):6-12.
[5] 王偉,萬雷,柴爽,等.骨質(zhì)疏松癥的中醫(yī)病因病機和分期治療[J].中醫(yī)正骨,2018,30(2):29-30.
[6] 陳娟,謝麗華,李生強,等.絕經(jīng)后骨質(zhì)疏松癥腎陰虛證關(guān)聯(lián)基因CLCF1 mRNA的表達研究[J].中國骨質(zhì)疏松雜志,2014,20(6):618-622.
[7] 鄧昶,周明旺,付志斌,等.骨質(zhì)疏松癥的中醫(yī)病因病機及其治療進展[J].中國骨質(zhì)疏松雜志,2017,23(8):1105-1111.
[8] 王穎穎,郭凱波.六味地黃丸(湯)拆方研究進展[J].浙江中西醫(yī)結(jié)合雜志,2017,27(4):349-352.
[9] ZHU Y,WANG Y M,JIA Y C,et al.Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway[J].Stem Cell Res Ther,2019,10(1):37.
[10] MENG J,ZHANG W,WANG C,et al.Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity[J].Biochem pharmacol,2020,171:113715.
[11] 黃佳純,林燕平,陳桐瑩,等.山茱萸新苷Ⅰ對成骨細(xì)胞的增殖及成骨分化的影響[J].中國骨質(zhì)疏松雜志,2020,26(1):1-5.
[12] LEE S,CHOI E,YANG S M,et al.Bioactive compounds from sclerotia extract of Poria cocos that control adipocyte and osteoblast differentiation[J].Bioorg Chem,2018,81:27-34.
[13] 梁博程,史曉林,許超,等.基于中藥系統(tǒng)藥理學(xué)方法研究六味地黃丸治療骨質(zhì)疏松癥的藥效成分、作用靶點及作用特點[J].中醫(yī)正骨,2019,31(4):1-7.
[14] 李玉星.基于OPG和RANKL探討六味地黃湯及其“補瀉”藥對干預(yù)絕經(jīng)后骨質(zhì)疏松模型大鼠的作用及其機制[D].長沙:湖南中醫(yī)藥大學(xué),2018.
[15] 陳娟,謝麗華,李生強,等.JAK/STAT通路介導(dǎo)的六味地黃丸對絕經(jīng)后骨質(zhì)疏松癥腎陰虛證的免疫調(diào)節(jié)作用[J].中華中醫(yī)藥雜志,2017,32(4):1747-1750.
[16] XIA B J,XU B,SUN Y,et al.The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis[J].J Ethnopharmacol,2014,153(1):133-141.
[17] 宮蕊.六味地黃丸干預(yù)絕經(jīng)后骨質(zhì)疏松與骨質(zhì)疏松相關(guān)疾病基因表達生物信息學(xué)分析研究[D].石家莊:河北醫(yī)科大學(xué),2019.
[18] 盧嚴(yán)方,林貫川,劉倩倩,等.六味地黃丸對絕經(jīng)期腎陰虛骨質(zhì)疏松癥的基因表達調(diào)控數(shù)據(jù)分析[J].中國骨質(zhì)疏松雜志,2017,23(3):350-356.
[19] 宋明,陳家旭,劉玥蕓,等.論蛋白質(zhì)組學(xué)與中醫(yī)證候研究[J].中華中醫(yī)藥雜志,2017,32(11):4804-4807.
[20] 郭潔梅,黃露露,賴興泉.六味地黃丸對腎陰虛證大鼠股骨髁松質(zhì)骨差異蛋白質(zhì)表達的影響[J].中華中醫(yī)藥雜志,2019,34(1):81-85.
[21] 方虹,魯林,陳煒.經(jīng)皮雌二醇聯(lián)合六味地黃丸治療絕經(jīng)期婦女骨質(zhì)疏松癥臨床研究[J].湖北中醫(yī)藥大學(xué)學(xué)報,2019,21(5):28-31.
[22] 王璽,羅志秀.六味地黃丸聯(lián)合鮭魚降鈣素對改善絕經(jīng)后骨質(zhì)疏松性疼痛癥狀的臨床研究[J].中國骨質(zhì)疏松雜志,2018,24(11):1485-1488.
[23] 王久清,張顯,郭慶功,等.阿侖膦酸鈉片聯(lián)合六味地黃丸治療女性絕經(jīng)后骨質(zhì)疏松癥40例臨床觀察[J].中國民族民間醫(yī)藥,2018,27(20):74-76.
[24] 蔡玉霞,張劍宇.補骨脂水煎劑對去卵巢骨質(zhì)疏松大鼠骨代謝的影響[J].中國組織工程研究與臨床康復(fù),2009,13(2):268-271.
[25] 梁秋峰,曹云桂,陳奇.六味地黃丸治療卵巢早衰的研究進展[J].醫(yī)學(xué)綜述,2019,25(17):3508-3512.
[26] 杜丹,魏潔玲,陳妙云.六味地黃丸聯(lián)合激素替代治療卵巢早衰的臨床研究[J].中華中醫(yī)藥學(xué)刊,2013,31(12):2738-2740.
相似文獻/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):12.
[3]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):19.
[6]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(04):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(04):3.
[11]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):7.
[12]歐國峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學(xué)研究進展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[16]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機制研究進展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細(xì)胞自噬的機制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):11.
[20]趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(04):26.